Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Effects of sarpogrelate on microvascular complications with type 2 diabetes
Publication date
01-04-2019
Published in
International Journal of Clinical Pharmacy / Issue 2/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00794-7

Other articles of this Issue 2/2019

International Journal of Clinical Pharmacy 2/2019 Go to the issue

Research Article

Implementation of a pharmaceutical care program for patients with hepatitis C treated with new direct-action antivirals

Research Article

Community pharmacists’ opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China

Research Article

The description and definition of Emergency Department Pharmacist Practitioners in the United Kingdom (the ENDPAPER study)

Research Article

Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications

Acknowledgments

Thank you to the reviewers 2018

Research Article

Impact of pharmacists’ interventions on physicians’ decision of a knowledge-based renal dosage adjustment system

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits